Phio Pharmaceuticals Corp. (PHIO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 17, 2025

$2.77

P/E Ratio

N/A

Market Cap

$11.54M

Jan 29, 2024Mar 1, 2024Apr 5, 2024May 9, 2024Jun 13, 2024Jul 17, 2024Aug 20, 2024Sep 25, 2024Oct 30, 2024Dec 3, 2024Jan 20, 2025$0.00$10.00
  • ONT
Description

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Metrics

Overview

  • HQMarlborough, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerPHIO
  • Price$2.77-4.81%

Trading Information

  • Market cap$11.54M
  • Float98.14%
  • Average Daily Volume (1m)21,430,153
  • Average Daily Volume (3m)6,206,273
  • EPS-$13.94

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$1.52M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$1.59M
  • EV-$1.97M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.54
Documents